US Patent Issued to BEIJING WEHAND-BIO PHARMACEUTICAL, GUANGXI WEHAND-BIO PHARMACEUTICAL on Jan. 20 for "Method for treating and preventing ulcerative colitis and method for DAI reduction" (Chinese Inventors)

ALEXANDRIA, Va., Jan. 20 -- United States Patent no. 12,527,830, issued on Jan. 20, was assigned to BEIJING WEHAND-BIO PHARMACEUTICAL Co. LTD (Beijing) and GUANGXI WEHAND-BIO PHARMACEUTICAL Co. LTD (Guangxi, China).

"Method for treating and preventing ulcerative colitis and method for DAI reduction" was invented by Yuling Liu (Beijing), Jun Ye (Beijing), Dongdong Liu (Beijing), Hongliang Wang (Beijing), Mo Wang (Beijing), Renjie Li (Beijing) and Yanfang Yang (Beijing).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention discloses a use of a mulberry (Morus alba L.) extract, including a method for treating ulcerative colitis, a method for preventing ulcerative colitis, and a method for reduction in Dis...